As shown in Table 5, both patients with leiomyosarcoma had an expression of proteins p16 and p53 in the immunohistochemical tests, indicating that we should pay more attention to the risk of leiomyosarcoma recurrence in those patients with expression of p16 and p53. This evidence concerns the gene TP53 and leiomyosarcoma.